Anabolic steroids have measurable muscle effects, but treatment of testosterone deficiency and performance enhancement are different contexts. Cardiovascular, hormonal and fertility outcomes belong in the same discussion.
More individual substance guides
Explore 10 anabolic steroids individually
Open each substance for its medical context, studied benefits, health considerations and evidence limits.
Testosterone: esters, studied benefits and health
Testosterone is an androgen hormone with physiological roles and specific medical uses. Separating the substance, formulation and treatment purpose makes the information easier to interpret.
Read this substance guide →AAS • NandroloneNandrolone: decanoate, medical evidence and health
Nandrolone has a history of medical use. This guide uses decanoate labeling to separate evidence in specific patients from broad muscle or joint claims.
Read this substance guide →AAS • OxandroloneOxandrolone: studied benefits, evidence and limitations
Oxandrolone has been studied for recovery and lean tissue in specific patient groups. Reading trials alongside product decisions helps distinguish measured benefits from broader claims.
Read this substance guide →AAS • StanozololStanozolol: clinical evidence, blood lipids and health
Stanozolol has clinical research and lipid data. Understanding the studied condition and actual outcome is more useful than judging appearance or total cholesterol alone.
Read this substance guide →AAS • MethandienoneMethandienone: body weight, muscle and evidence
Older methandienone trials in weightlifters reported body-weight and performance changes. Weight gain is not identical to muscle gain; the measurement method matters.
Read this substance guide →AAS • OxymetholoneOxymetholone: anemia evidence, blood effects and health
Oxymetholone has a medical history in selected anemias. Understanding the cause of anemia and the treatment outcome helps avoid turning red-cell findings into general performance claims.
Read this substance guide →AAS • MethenoloneMethenolone: metenolone names and evidence
Methenolone, also spelled metenolone, is a synthetic anabolic steroid. Separating substance, ester and trade names helps avoid applying one formulation’s evidence to every product.
Read this substance guide →AAS • DrostanoloneDrostanolone: historical research and health context
Drostanolone appears in historical medical research on androgen therapy. That history needs to be separated from claims about physique outcomes in healthy people.
Read this substance guide →AAS • TrenboloneTrenbolone: veterinary evidence and human limitations
Trenbolone is often discussed in physique settings. The official evidence reviewed here concerns trenbolone acetate in animals, which requires a clear boundary when interpreting human claims.
Read this substance guide →AAS • BoldenoneBoldenone: undecylenate and veterinary evidence
Boldenone undecylenate appears in the veterinary product Equipoise. Reading the original indication and target species clarifies the context of claimed benefits.
Read this substance guide →What are AAS?
Anabolic-androgenic steroids (AAS) relate to testosterone and androgen effects. They differ from corticosteroids used for inflammatory conditions. The word steroid alone does not identify a medicine’s purpose: the substance and treatment indication matter. NIDA explains anabolic steroids.
Evidence for benefits has two different contexts
Treating testosterone deficiency
The Endocrine Society guideline bases diagnosis on symptoms and unequivocally, consistently low testosterone confirmed with appropriate testing. Indicated treatment aims to address deficiency-related symptoms. Benefits in this patient population are not evidence that everyone seeking muscle gain should receive hormones.
Muscle and strength effects in research
The Bhasin trial found increases in fat-free mass, muscle size and strength with testosterone, including effects alongside resistance training. This establishes measurable muscle effects in that study. It does not establish the long-term safety of nonmedical use or validate every AAS compound.
Limitations and health outcomes to consider
NIDA describes potential cardiovascular, liver, kidney, hormonal, fertility and mood effects of nonmedical AAS use. Physique outcomes should therefore be considered alongside health rather than used as a complete health measure.
When symptoms suggest a hormonal problem, bring the symptom timeline, previous results and exposure history for assessment. Discuss fertility plans before treatment decisions. A single testosterone result is not enough to establish the diagnosis.
How to assess a claim
- Was the study in people with hormone deficiency or normal hormone levels?
- Did it measure an outcome such as strength, or only report subjective impressions and photographs?
- How long were participants followed, and which adverse effects were recorded?
- Is the claim about the same substance and population as the study?
Prepare useful appointment questions
Write down the problem you want to address, when it started, any previous results and your fertility goals. This helps focus the assessment on the cause and on benefits relevant to the individual.
Frequently asked questions
Are AAS and corticosteroids the same?
No. AAS relate to testosterone and androgen effects; corticosteroids are used in inflammatory conditions. The specific medicine and indication matter.
Does a muscle-gain study prove safety?
No. Muscle change is one outcome. Long-term safety also requires follow-up and assessment of other health outcomes.